03191nam 2200709 a 450 991082911190332120200520144314.09786612348259978128234825712823482569780470518137047051813897804705181440470518146(CKB)1000000000377297(EBL)470145(OCoLC)609848709(SSID)ssj0000302308(PQKBManifestationID)11212294(PQKBTitleCode)TC0000302308(PQKBWorkID)10267089(PQKB)10325685(MiAaPQ)EBC470145(Au-PeEL)EBL470145(CaPaEBR)ebr10297756(CaONFJC)MIL234825(OCoLC)144568198(FINmELB)ELB178416(Perlego)2770913(EXLCZ)99100000000037729720070610d2007 uy 0engur|n|---|||||txtccrManagement strategies in antithrombotic therapy /by Arman Askari and Adrian W. Messerli1st ed.Chichester ;Hoboken, N.J. John Wiley and Sonsc20071 online resource (372 p.)Description based upon print version of record.9780470319383 0470319380 Includes bibliographical references and index.Thrombosis and antithrombotics in vascular disease -- Aspirin -- Thienopyridines, ticlopidine, and clopidogrel -- Platelet glycoprotein IIb/IIIa inhibitors -- Unfractionated heparin -- Low-molecular-weight heparins -- Direct thrombin inhibitors -- Fibrinolytic agents -- Acute ST-segment elevation myocardial infarction -- Acute coronary syndromes / non-ST-segment elevation myocardial infarction -- Anticoagulation strategies for patients undergoing percutaneous coronary intervention -- Venous thromboembolic disease -- Heparin-induced thrombocytopenia.Intravascular thrombus formation remains one of the most significant problems in cardiovascular medicine. It underlies the clinical presentation of acute coronary syndromes, including unstable angina and non-ST-segment elevation myocardial infarction (NSTEMI) and ST-segment elevation myocardial infarction. More and more individuals are stricken with an acute MI and undergo a percutaneous coronary intervention (PCI). Several reasons apply, including an increasingly aged population, the growing burden of chronic risk factors such as diabetes, obesity, sedentary behaviour, and improvements in eThrombolytic therapyThrombosisTreatmentFibrinolytic agentsThrombolytic therapy.ThrombosisTreatment.Fibrinolytic agents.616.1/42Askari Arman T1670666Messerli Adrian W1670667MiAaPQMiAaPQMiAaPQBOOK9910829111903321Management strategies in antithrombotic therapy4032673UNINA01355nam2 22003131i 450 UON0042549720231205104845.43005-212-3116-720130529d1993 |0itac50 baengGB|||| 1||||ˆ7.: ‰November 1928-February 1930Keith SagarJames T. BoultonCambridge [etc.]Cambridge university press1993xxvi, 683 p.ill.23 cm.001UON004254652001 ˆThe ‰Letters of D.H.LawrenceJames T. Boulton210 Cambridge [etc.]Cambridge university1969215 xxix, 579 p.23 cm.7LAWRENCE DAVID HERBERTUONC039601FICambridgeUONL000022823.914Narrativa inglese, 1945-199921LAWRENCEDavid HerbertUONV11259560980SAGARKeithUONV120119166697BOULTONJames ThompsonUONV113796Cambridge University PressUONV245943650ITSOL20250620RICASIBA - SISTEMA BIBLIOTECARIO DI ATENEOUONSIUON00425497SIBA - SISTEMA BIBLIOTECARIO DI ATENEOSI Angl 10 CLWL 30 SI LO 61107 5 30 BuonoNovember 1928-February 19301184939UNIOR